CAS No.
[871700-17-3(Unlabeled)]
Storage Condition
Store at freezer (-20°C) for long term storage
Synonyms
N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]acetamide-13C6
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Refer MSDS for complete information
Trametinib-13C6 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Trametinib-13C6 usage and description
[13C6]-Trametinib is a chemical compound that is used in cancer therapy. It is known to inhibit the activity of the MEK1 and MEK2 proteins, which are responsible for cell growth and division. As a result, [13C6]-Trametinib has been shown to be effective in treating a variety of cancers, including melanoma, thyroid cancer, and non-small cell lung cancer.
The chemical formula of [13C6]-Trametinib is C26H23ClF2NO4, and its molecular weight is 615.92 g/mol. The compound contains six carbon-13 isotopes, which can be used for isotopic labeling studies in biological systems.
In terms of usage, [13C6]-Trametinib is typically administered orally in the form of tablets. The recommended dosage varies depending on the type of cancer being treated and the patient's individual factors, such as age, weight, and overall health.
Like many other cancer drugs, [13C6]-Trametinib can have side effects, including nausea, vomiting, diarrhea, fatigue, and skin rash. Patients should be carefully monitored for any adverse effects and should report any concerning symptoms to their healthcare provider.
Overall, [13C6]-Trametinib is an important tool in the fight against cancer and is currently undergoing further clinical trials to determine its potential in other types of cancer therapy.
